Abnormal blood flow and red blood cell deformability in severe malaria

Parasitology Today

Volumn 16, Issue 6, 2000, Pages 228-232

  Dondorp, Arjen M ^a   Kager, Piet A ^a   Vreeken, Johan ^a   White, Nicholas J ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD FLOW; BLOOD PRESSURE; BLOOD RHEOLOGY; BLOOD VESSEL DIAMETER; BLOOD VISCOSITY; BRAIN MALARIA; CELL AGGREGATION; ERYTHROCYTE STRUCTURE; HUMAN; MALARIA FALCIPARUM; MICROCIRCULATION; NONHUMAN; PLASMODIUM FALCIPARUM; REVIEW;

ADULT; ANIMALS; BLOOD FLOW VELOCITY; CHILD; ERYTHROCYTE DEFORMABILITY; HEMORHEOLOGY; HUMANS; MALARIA, FALCIPARUM; MICROCIRCULATION; PLASMODIUM FALCIPARUM;

EID: 0034212451     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(00)01666-5     Document Type: Review

References (53)

1. Control of Tropical Diseases. Severe and complicated malaria, 2nd edition. Trans. R. Soc. Trop. Med. Hyg. 84(Suppl. 2):1990;1-65.
2. Snow R.et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet. 349:1997;1650-1654.
3. Luxemburger C.et al. Morbidity from malaria among a Karen population living on the Thai-Burmese border. Trans. R. Soc. Trop. Med. Hyg. 90:1996;105-112.
4. White N.J., Ho M. The pathophysiology of malaria. Baker J.R., Muller R. Advances in Parasitology 31. 1992;84-175 Academic Press.
5. Supanaranond W.et al. Abnormal circulatory control in falciparum malaria: the effects of antimalarial drugs. Eur. J. Clin. Pharmacol. 44:1993;325-329.
6. Warrell D.A.et al. Cerebral anaerobic glycolysis and reduced cerebral oxygen transport in human cerebral malaria. Lancet. I:1988;534-538.
7. Macpherson G.G.et al. Human cerebral malaria .A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 119:1985;385-401.
8. Ho M., White N.J. Molecular mechanisms of cytoadherence in malaria. Am. J. Physiol. 1999;C1231-C1242.
9. Nash G.B.et al. Rheological analysis of the adhesive interactions of red blood cells parasitized by Plasmodium falciparum. Blood. 79:1992;798-807.
10. Raventos-Suarez C.et al. Membrane knobs are required for the microcirculatory obstruction induced by Plasmodium falciparum-infected erythrocytes. Proc. Natl. Acad. Sci. U. S. A. 82:1985;3829-3833.
11. Matrai A.et al. Biophysics of blood. Chien S.et al. Clinical Hemorheology. 1987;9-73 Martinus Nijhoff Publishers.
12. Sitprija V.et al. Renal failure in malaria: a pathophysiologic study. Nephron. 18:1977;277-287.
13. Dintenfass L. Inversion of the Fåhreus-Lindqvist phenomenon in blood flow through capillaries with diminishing radius. Nature. 215:1967;1099-1100.
14. Cranston H.A.et al. Plasmodium falciparum maturation abolishes physiologic RBC deformability. Science. 223:1983;400-402.
15. Nash G.B.et al. Abnormalities in the mechanical properties of red blood cells caused by Plasmodium falciparum. Blood. 74:1989;855-860.
16. Dondorp A.M.et al. Prognostic significance of reduced RBC deformability in severe falciparum malaria. Am. J. Trop. Med. Hyg. 57:1997;507-511.
17. Paulitschke M., Nash G.B. Membrane rigidity of red blood cells parasitized by different strains of Plasmodium falciparum. J. Lab. Clin. Med. 122:1993;581-589.
18. Coppel R.L. Repeat structures in a Plasmodium falciparum protein that binds human erythrocyte protein 4.1. Mol. Biochem. Parasitol. 50:1992;335-348.
19. Foley M.et al. The ring-infected erythrocyte surface antigen of Plasmodium falciparum associates with spectrin in the erythrocyte membrane. Mol. Biochem. Parasitol. 46:1991;137-148.
20. Hunt N.H., Stocker R. Oxidative stress and the redox status of malaria-infected erythrocytes. Blood Cells. 16:1990;499-526.
21. Lee M.V.et al. Diminished red blood cell deformability in uncomplicated human malaria. A preliminary report. J. Med. 13:1992;479-485.
22. Areekul S., Yamarat P. Alterations in the viscosity and deformability of red cells with Plasmodium falciparum. J. Med. Assoc. Thai. 71:1988;196-201.
23. Nauman K.M.et al. Plasmodium falciparum exo-antigen alters erythrocyte membrane deformability. FEBS Lett. 292:1991;95-97.
24. Nash G.B.et al. Rheological properties of rosettes formed by red blood cells parasitized by Plasmodium falciparum. Br. J. Haematol. 82:1992;757-763.
25. Kaul D.K.et al. Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood. 78:1991;812-819.
26. Aikawa M.et al. The pathology of human cerebral malaria. Am. J. Trop. Med. Hyg. 43:1990;30-37.
27. Pongponratn E.et al. Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am. J. Trop. Med. Hyg. 44:1991;168-175.
28. Silamut K.et al. A quantitative analysis of the microvascular human brain. Am. J. Pathol. 155:1999;395-410.
29. Ho M.et al. Clinical correlates of in vitro Plasmodium falciparum cytoadherence. Infect. Immun. 59:1991;873-878.
30. Goldring J.D.et al. Plasmodium falciparum: diversity of isolates from Malawi in their cytoadherence to melanoma cells and monocytes in vitro. Br. J. Haematol. 81:1992;413-418.
31. Newbold C.et al. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 57:1997;389-398.
32. Krishna S.et al. Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. Trans. R. Soc. Trop. Med. Hyg. 88:1994;67-73.
33. Marsh K.et al. Indicators of life-threatening malaria in African children. New Engl. J. Med. 332:1995;1399-1404.
34. Molyneux M.E.et al. Reduced hepatic flow and intestinal malabsorption in severe falciparum malaria. Am. J. Trop. Med. Hyg. 40:1989;470-476.
35. Secomb T.W.et al. A model for red blood cell motion in glycocalyx lined capillaries. Am. J. Physiol. 274:1998;1016-1022.
36. Schmidt-Schonbein G.W.et al. Cell distribution in capillary networks. Microvasc. Res. 19:1980;18-44.
37. White N.J.et al. Pathophysiological and prognostic significance of cerebrospinal-fluid lactate in cerebral malaria. Lancet. I:1985;776-778.
38. Carlson J.et al. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting activity. Lancet. 336:1990;1457-1460.
39. Treutiger C.J.et al. Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am. J. Trop. Med. Hyg. 46:1992;503-510.
40. Rowe A.et al. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect. Immun. 63:1995;2323-2326.
41. Al Yaman F.et al. Human cerebral malaria: lack of significant association between erythrocyte rosetting and disease severity. Trans. R. Soc. Trop. Med. Hyg. 89:1995;55-58.
42. Lowe B.S.et al. All four species of human malaria parasites form rosettes. Trans. R. Soc. Trop. Med. Hyg. 92:1998;526.
43. Phillips R.E., Pasvol G. Anaemia of Plasmodium falciparum malaria. Bailliere's Clin. Haematol. 5:1992;315-320.
44. Dondorp A.M.et al. RBC deformability as a predictor of anaemia in falciparum malaria. Am. J. Trop. Med. Hyg. 60:1999;733-737.
45. Ho M.et al. Splenic Fc receptor function in host defense and anemia in acute Plasmodium falciparum malaria. J. Infect. Dis. 161:1990;555-561.
46. Looaresuwan S.et al. Dynamic alteration in splenic function during acute falciparum malaria. New Engl. J. Med. 317:1987;675-679.
47. Udonsangpetch R.et al. Antimalarial drugs reduce cytoadherence and rosetting of Plasmodium falciparum. J. Infect. Dis. 173:1996;691-698.
48. Boele van Hensbroek M.et al. A trial of artemether or quinine in children with cerebral malaria. New Engl. J. Med. 335:1996;69-75.
49. Hien T.T.et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. New Engl. J. Med. 335:1996;76-83.
50. Hemmer C.J.et al. Neither heparin nor actylsalicylic acid influence the clinical course in human Plasmodium falciparum malaria: a prospective randomized study. Am. J. Trop. Med. Hyg. 45:1991;608-612.
51. Di Perri G.et al. Pentoxifyllin as a supportive agent in the treatment of cerebral malaria in children. J. Infect. Dis. 171:1995;1317-1322.
52. Hemmer C.J.et al. Supportive pentoxifyllin in falciparum malaria: no effect on tumor necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study. Am. J. Trop. Med. Hyg. 56:1997;397-403.
53. Editorial (1990) Exchange transfusion in falciparum malaria. Lancet 335, 324-325.